China SXT Pharmaceuticals Statistics
Total Valuation
SXTC has a market cap or net worth of $163.60 million. The enterprise value is $146.35 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
SXTC has 116.03 million shares outstanding. The number of shares has increased by 1,212.67% in one year.
| Current Share Class | 116.03M |
| Shares Outstanding | 116.03M |
| Shares Change (YoY) | +1,212.67% |
| Shares Change (QoQ) | +504.74% |
| Owned by Insiders (%) | 35.33% |
| Owned by Institutions (%) | 0.27% |
| Float | 75.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.15 |
| Forward PS | n/a |
| PB Ratio | 1.26 |
| P/TBV Ratio | 10.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 84.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.54 |
| Quick Ratio | 3.33 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.21 |
Financial Efficiency
Return on equity (ROE) is -22.50% and return on invested capital (ROIC) is -9.84%.
| Return on Equity (ROE) | -22.50% |
| Return on Assets (ROA) | -7.48% |
| Return on Invested Capital (ROIC) | -9.84% |
| Return on Capital Employed (ROCE) | -17.13% |
| Revenue Per Employee | $23,212 |
| Profits Per Employee | -$44,049 |
| Employee Count | 75 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 1.42 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.02% in the last 52 weeks. The beta is 1.45, so SXTC's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | -53.02% |
| 50-Day Moving Average | 1.44 |
| 200-Day Moving Average | 1.93 |
| Relative Strength Index (RSI) | 49.86 |
| Average Volume (20 Days) | 273,196 |
Short Selling Information
| Short Interest | 94,603 |
| Short Previous Month | 99,983 |
| Short % of Shares Out | 0.08% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.69 |
Income Statement
In the last 12 months, SXTC had revenue of $1.74 million and -$3.30 million in losses. Loss per share was -$2.32.
| Revenue | 1.74M |
| Gross Profit | 367,427 |
| Operating Income | -2.68M |
| Pretax Income | -3.30M |
| Net Income | -3.30M |
| EBITDA | -2.60M |
| EBIT | -2.68M |
| Loss Per Share | -$2.32 |
Full Income StatementBalance Sheet
The company has $18.24 million in cash and $983,877 in debt, giving a net cash position of $17.25 million or $0.15 per share.
| Cash & Cash Equivalents | 18.24M |
| Total Debt | 983,877 |
| Net Cash | 17.25M |
| Net Cash Per Share | $0.15 |
| Equity (Book Value) | 15.44M |
| Book Value Per Share | 1.12 |
| Working Capital | 15.28M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.35 million and capital expenditures -$2,023, giving a free cash flow of -$2.35 million.
| Operating Cash Flow | -2.35M |
| Capital Expenditures | -2,023 |
| Free Cash Flow | -2.35M |
| FCF Per Share | -$0.02 |
Full Cash Flow StatementMargins
Gross margin is 21.11%, with operating and profit margins of -153.97% and -189.77%.
| Gross Margin | 21.11% |
| Operating Margin | -153.97% |
| Pretax Margin | -189.77% |
| Profit Margin | -189.77% |
| EBITDA Margin | -149.24% |
| EBIT Margin | -153.97% |
| FCF Margin | n/a |